Facebook
Twitter
LinkedIn
ForwardSummit on Cancer Health Disparities (SCHD24) - Enduring Recorded Webcast
This accredited continuing education activity, Summit on Cancer Health Disparities (SCHD24) - Enduring Recorded Webcast, is recorded from the live conference held from 4/26/2024 to 4/28/2024.
If you participated in the live conference titled - Summit on Cancer Health Disparities (SCHD24) from 4/26/2024 to 4/28/2024 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is recorded content from that conference from 4/26/2024 to 4/28/2024. However, you can still enroll in this activity and review the contents as needed.
This recorded webcast, The Summit on Cancer Health Disparities (SCHD24), is one of the largest gatherings of cancer care professionals interested in cancer health disparities with a focus on achieving health equity. SCHD24 featured lectures, panel discussions, and debates among leaders across the spectrum of cancer care delivery. This conference brought together oncology professionals, cancer disparity researchers, and other stakeholders to discuss factors leading to cancer health disparities. A focus of the conference was to explore how these factors can be mitigated to optimize the outcomes of cancer patients. A distinctive feature of this conference was case-based discussions that described a problem, how it was solved, and the lessons learned.
SCHD24 is an accredited continuing education activity (CME activity) that fostered collaborative interdisciplinary interactions and partnerships to stimulate the development of new research and clinical practices that reduce cancer health disparities and improve outcomes of the diverse patient population.
REGISTRATION FEES:
This activity is free for all.
Target Audience
- Oncologists
- Oncology Nurse Practitioners & Physician Assistants
- Oncology Pharmacists
- Oncology Nurses
- Residents/Fellow
- Researchers
Organizing Committee
Program Director:
Dr. Binay Shah - Binaytara Foundation
Conference Co-Chairs:
Dr. Ana María López - Sidney Kimmel Cancer Center, Thomas Jefferson University
Dr. David Aboulafia - Virginia Mason Medical Center
Dr. Hannah Linden - University of Washington and Fred Hutchinson Cancer Center
Organizing Committee:
Dr. Martha Pritchett Mims - Baylor College of Medicine
Dr. Jorge Cortes - Georgia Cancer Center at Augusta University
Dr. Kamran Mirza - University of Michigan
Dr. Ishwaria Subbiah - Sarah Cannon Research Institute
Dr. Siddhartha Yadav - Mayo Clinic
Dr. Dan Milner - Union for International Cancer Control
Abstract Committee Co-Chairs:
Dr. Martha Pritchett Mims - Baylor College of Medicine
Dr. Darya Kizub - MD Anderson Cancer Center
Dr. Siddhartha Yadav - Mayo Clinic
Abstract Committee:
Dr. Ronan Hsieh - University of Washington and Fred Hutchinson Cancer Center
Dr. Srinivas Tantravahi - University of Utah Huntsman Cancer Institute
Dr. Manisha Bhattacharya - University of Pittsburgh Medical Center
Dr. Kamran Mirza - University of Michigan
Dr. Gregory Vidal - West Cancer Center
Dr. Ursa Brown-Glaberman - University of New Mexico Comprehensive Cancer Center
Dr. Fengting Yan - Swedish Cancer Institute
Dr. Dipesh Uprety - Karmanos Cancer Institute
Media and Publications Committee Co-Chairs:
Dr. Ishwaria Subbiah - Sarah Cannon Research Institute
Dr. Kamran Mirza - University of Michigan
Dr. Umang Swami - University of Utah Huntsman Cancer Institute
Sponsorship Committee Chair:
Dr. Fengting Yan - Swedish Cancer Institute
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
- Review barriers to using multidisciplinary cancer care and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.
- Discuss newer technologies and their impact on cancer health disparities.
- Review the effectiveness of various interventional approaches and incorporate evidence-based strategies to minimize cancer health disparities in specific populations.
- Describe challenges and develop novel approaches, including technology utilization, to improve underrepresented communities' participation in clinical trials.
- Discuss the role of government policies and health care legislation in cancer health disparities and policy changes needed to improve access to cancer care.
This educational activity features recorded videos from the live webinar titled Summit on Cancer Health Disparities (SCHD24)
held April 26-28th, 2024.
The videos are placed in the following order. Feel free to view the content that is relevant to you.
Participants should claim continuing education credits to the extent of their participation.
1 hour and 30 minutes — Session 1: Understanding Disparities
Session Chairs: David Aboulafia, MD and Gita Suneja, MD, MS
Introduction by Session Chairs
Unpacking Disparities to Inform Action - Michele Andrasik, PhD
Best Practices in Supporting LGBTQ+ Communities - Nakita Venus and Elle Brooks, MPH
Panel Discussion - Alan Brownell; Derrick Mapp
1 hour and 30 minutes — Session 2: Disparities: Access To Diagnostics and Care
Session Chairs: Mark Pegram, MD and Kamran M. Mirza, MD, PhD
Pathology - Kamran M. Mirza, MD, PhD
Precision Oncology - Siddhartha Devarakonda, MD
GU Cancer - Ulka Vaishampayan, MD
Hematologic Malignancies - Irum Khan, MD
Lung Cancer - Nicholas P. Giustini, MD
50 minutes — Session 3: Caring for the Carers: Diversity, Inclusion, and Professional Well-Being of the Global Community of Cancer Care Professionals
Session Chair: Ishwaria Subbiah, MD, MS, FASCO
On Well-Being: Background and Rationale - Ana María López, MD, MPH, MACP
On Well-Being Transitions: Training and Trainees - Carrie Fisher, DO
An Experiential Session with 'the Best Medicine' - Carrie A. Horwitch, MD, MPH, MACP
Panel Discussion
1 hour — Session 4: Integration of Technology into Cancer Care
Session Chair: Manish Kohli, MD
Artificial Intelligence to Facilitate Cancer Care - Joseph Finkelstein, MD, PhD, FAMIA, FACMI
Digital Innovations in Cancer Care - Ana María López, MD, MPH, MACP
Using Deep Learning and Patient-Reported Data to Predict Symptom Deterioration during a Chemotherapy Course - Aref Smiley, PhD
Panel Discussion
1 hour and 30 minutes — Session 5: Achieving Quality Through Value-Based Models for Cancer Care: Practical Solutions
Session Chair: Ana María López, MD, MPH, MACP
ASCO Certified Patient-Centered Cancer Care Standards - Stephen S. Grubbs, MD, FASCO
Value for Whom? How to Make Value for Patients - Barbara L. McAneny, MD
Patient Perspectives on Cancer Care Delivery & Survivorship - Shelley Fuld Nasso, MPP
Beyond the Measures: Advancing Quality in Healthcare - Michael Barr, MD, MBA, MACP, FRCP
Panel Discussion
1 hour and 30 minutes — Session 6: Community Engagement
Session Chair: Martha Pritchett Mims, MD, PhD
A Latino Lens: Listening to the Community to Fuel Outreach and Education - Amelie G. Ramirez, DrPH, MPH
OPTIMISE Oncology - Primary Care Partnership to Improve Comprehensive Survivorship Care - Hoda J. Badr, PhD
Shifting the lens: Engagement of Tribal communities in cancer clinical trials - Andrew Sussman, PhD, MCRP
Reaching Spanish Preferring Populations with Cancer Education and Screening - Susan T. Vadaparampil, PhD, MPH
Panel Discussion
1 hour — Session 7: Drug Shortage
Session Chairs: Hannah M. Linden, MD, FACP and Shailender Bhatia, MD
Impossible Choices in Challenging Circumstances: Dealing with Decades of Drug Shortages - Karen Hagerty, MD
Drug shortages: Upstream Factors and Policy Solutions - Mariana Peixoto Socal, MD, PhD
Panel Discussion - W. Thomas Purcell, MD, MBA
1 hour — Session 8: Oncology Leaders' Approach to Cancer Health Disparities
Moderator: Amelie G. Ramirez, DrPH, MPH
Panelists: Margaret Foti, PhD, MD (hc); Jorge E. Cortes, MD; Joseph R. Mikhael, MD, MEd, FRCPC, FACP
1 hour and 30 minutes — Session 9: Clinical Trials & Research Diversity
Session Chair: Jorge E. Cortes, MD
Access to Clinical Trials: An Equity and Social Justice Opportunity - Nadine J. Barrett, PhD, MA, MS
Can We Increase Accrual of Minorities in Rural Areas of the Country? A 12 Year Journey - Sharad Ghamande, MD, FACOG
Using Culturally-Tailored Edutainment Videos to Facilitate Recruitment and Decision-Making about Cancer Clinical Trials - Vida Henderson, PhD, PharmD, MPH, MFA
A Simple, Intuitive-Approach for Assessing Clinical Trial Data to Evaluate Outcomes for Under-Represented Patient Populations - Roger M. Stein, PhD
"How can you begin to think about a clinical trial when you can't get food on the table?" A Community Health Worker-led Health Related Social Needs Intervention and the Impact on Clinical Trial Education and Accrual - Manali I. Patel, MD, MPH, MS, FASCO
Panel Discussion - Jerald Radich, MD; Jason A. Mendoza, MD, MPH
1 hour and 30 minutes — Session 10: Global Oncology
Session Chair: Dan A. Milner, Jr., MD, MSc(EPi), MBA, FASCP
Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
New Technologies to Enhance Innate Immunity for the Prevention and Treatment of Cancer in Low Resource Settings - Corey Casper, MD, MPH
Developing Global Cancer Mentorship: A Pilot Experience with Rwanda - Regine Nshimiyimana Maniraho, DNP, BPharm, FNP, AGACNP, AOCNP
Access to Medications: Cases Studies in Solutions - Dan A. Milner, Jr., MD, MSc(EPi), MBA, FASCP
Case Study: Behind the Scenes of 'Streamlined' Care - Joseph Rosales, MD
Panel Discussion - Yogendra P. Singh, MBBS, MD
1 hour and 30 minutes — Debate: Is Universal Healthcare A Solution to U.S. Healthcare Disparities?
Moderators: Manisha Bhattacharya, MD, MBA and Aaron Goodman, MD
Panelists: Karen E. Knudsen, MBA, PhD (CEO of the American Cancer Society); Sen. Manka Dhingra (Deputy Majority Leader of the Washington State Senate); Barbara L. McAneny, MD (Past-President of the American Medical Association); Willie Underwood, III, MD, MSc, MPH (Chair of the American Medical Association Board of Trustees); Rep. Adam Smith (Representative for Washington's 9th Congressional District); Isaac Opole, MD, MBChB, PhD, FACP (President of the American College of Physicians)
FACULTY
COURSE DIRECTOR(S)
Binay Shah, MD, MHA has no relevant financial relationships to disclose at this time.
CONFERENCE CHAIR(S)
David Aboulafia, MD has no relevant financial relationships to disclose at this time.
Hannah Linden, MD FACP has a financial relationship (Grant Or Contract) with Veru Pharmaceuticals; financial relationship (Professional Services) with Gillead; financial relationship (Grant Or Contract) with Tolmar; financial relationship (Grant Or Contract) with GE Healthcare; financial relationship (Grant Or Contract) with Sanofi.
Ana Maria Lopez, MD, MPH has no relevant financial relationships to disclose at this time.
SESSION CHAIR(S)
David Aboulafia, MD has no relevant financial relationships to disclose at this time.
Shailender Bhatia, MD has a financial relationship (Grant Or Contract) with Amphivena; financial relationship (Grant Or Contract) with Exicure; financial relationship (Grant Or Contract) with Nektar Therapeutics; financial relationship (Grant Or Contract) with Agenus; financial relationship (Grant Or Contract) with EMD Serono; financial relationship (Grant Or Contract) with Merck; financial relationship (Grant Or Contract) with Xencor; financial relationship (Grant Or Contract) with 4SC; financial relationship (Grant Or Contract) with Regeneron (fka Checkmate Pharmaceuticals); financial relationship (Grant Or Contract) with Kuni Foundation; financial relationship (Grant Or Contract) with Trisalus Life Sciences; financial relationship (Grant Or Contract) with Bristol Meyers Squibb; financial relationship (Grant Or Contract) with Incyte; financial relationship (Grant Or Contract) with Novartis.
Jorge Cortes, MD has a financial relationship (Other) with Novartis; financial relationship (Other) with Sun Pharma; financial relationship (Other) with Abbvie; financial relationship (Other) with Takeda; financial relationship (Other) with Pfizer.
Manish Kohli has a financial relationship (Travel) with Triomics; financial relationship (Professional Services) with Tempus Inc; financial relationship (Professional Services) with Janssen Scientific Affairs, LLC; financial relationship (Travel) with Apollo Hospital Enterprise Limited.
Ana Maria Lopez, MD, MPH has no relevant financial relationships to disclose at this time.
Danny Milner, Jr, MD, MSc, MBA has no relevant financial relationships to disclose at this time.
Martha Mims has a financial relationship (Stock) with Biogen IDEC; financial relationship (Stock) with Amgen; financial relationship (Grant Or Contract) with Incyte; financial relationship (Grant Or Contract) with Aveo; financial relationship (Grant Or Contract) with Celgene.
Kamran Mirza, MD PhD has a financial relationship (Independent contractor) with Astellas Pharma.
Mark Pegram, MD has a financial relationship (Employment) with Rain Oncology; financial relationship (Other) with Gilead; financial relationship (Other) with Novartis.
Gita Suneja, MD, MSHP has no relevant financial relationships to disclose at this time.
Siddhartha Yadav, Siddhartha Yadav, MD, FACP has a financial relationship (Other) with Repare Therapeutics; financial relationship (Other) with Astrazenca ; financial relationship (Other) with Astrazeneca.
SPEAKER/TOPIC PRESENTER(S)
Michele Andrasik, PhD, EdM, MA, MS has no relevant financial relationships to disclose at this time.
Nadine Barrett, PhD, MA., MS has no relevant financial relationships to disclose at this time.
Elle Brooks has no relevant financial relationships to disclose at this time.
Alan Brownell has no relevant financial relationships to disclose at this time.
Siddhartha Devarakonda, MBBS, MD has a financial relationship (Other) with Merus; financial relationship (Other) with Genetech; financial relationship (Other) with AZ; financial relationship (Other) with Jazz.
Manka Dhingra has no relevant financial relationships to disclose at this time.
Joseph Finkelstein, MD, PhD, FAMIA, FACMI has no relevant financial relationships to disclose at this time.
Carrie Fisher, DO has no relevant financial relationships to disclose at this time.
Margaret Foti has no relevant financial relationships to disclose at this time.
Nicholas Giustini, MD has a financial relationship (Other) with Curio Science.
Stephen Grubbs has no relevant financial relationships to disclose at this time.
Karen Hagerty has no relevant financial relationships to disclose at this time.
Carrie Horwitch, MD, MPH has no relevant financial relationships to disclose at this time.
Irum Khan, MD, MS has a financial relationship (Professional Services) with BMS.
Karen Knudsen, MBA, PhD has no relevant financial relationships to disclose at this time.
Roger M Stein has no relevant financial relationships to disclose at this time.
Derrick Mapp has no relevant financial relationships to disclose at this time.
Jason Mendoza, MD, MPH has no relevant financial relationships to disclose at this time.
Joseph Mikhael, MD, MEd, FRCPC has a financial relationship (Independent contractor) with BMS; financial relationship (Independent contractor) with Amgen; financial relationship (Independent contractor) with Sanofi; financial relationship (Independent contractor) with Janssen.
Regine Nshimiyimana Maniraho, DNP, BPharm, FNP, AGACNP, AOCNP has no relevant financial relationships to disclose at this time.
Isaac Opole has no relevant financial relationships to disclose at this time.
Tom purcell, MD, MBA has no relevant financial relationships to disclose at this time.
Jerald Radich has a financial relationship (Other) with Cepheid; financial relationship (Other) with NuProbe; financial relationship (Other) with Novartis.
Amelie Ramirez, DrPH has no relevant financial relationships to disclose at this time.
Adam Smith has no relevant financial relationships to disclose at this time.
Mariana Socal, MD, PhD, MS, MPP has no relevant financial relationships to disclose at this time.
Ishwaria Subbiah, MD, MS has no relevant financial relationships to disclose at this time.
Willie Underwood, III has no relevant financial relationships to disclose at this time.
Susan Vadaparampil has no relevant financial relationships to disclose at this time.
Ulka Vaishampayan, MD has a financial relationship (Professional Services) with BMS; financial relationship (Professional Services) with Bayer; financial relationship (Professional Services) with Pfizer; financial relationship (Professional Services) with Exelixis; financial relationship (Professional Services) with Gilead; financial relationship (Professional Services) with Merck; financial relationship (Professional Services) with sanofi.
Nakita Venus has no relevant financial relationships to disclose at this time.
CASE PRESENTER(S)
Hoda Badr, PhD has no relevant financial relationships to disclose at this time.
Michael Barr, MD, MBA, MACP, FRCP has no relevant financial relationships to disclose at this time.
Corey Casper, MD, MPH has a financial relationship (Grant Or Contract) with Janssen Pharmaceutical; financial relationship (Grant Or Contract) with ImmunityBio; financial relationship (Stock Options) with Viracta Therapeutics; financial relationship (Independent contractor) with Recordati Rare Disease.
Shelley Fuld Nasso, MPP has no relevant financial relationships to disclose at this time.
Sharad Ghamande has a financial relationship (Professional Services) with GSK.
Vida Henderson has no relevant financial relationships to disclose at this time.
Barbara McAneny has no relevant financial relationships to disclose at this time.
Manali Patel, MD, MPH, MS, FASCO has no relevant financial relationships to disclose at this time.
Joseph Rosales, MD has no relevant financial relationships to disclose at this time.
Yogendra Singh has no relevant financial relationships to disclose at this time.
Aref Smiley has no relevant financial relationships to disclose at this time.
Andrew Sussman, PhD, MCRP has no relevant financial relationships to disclose at this time.
MODERATOR(S)
Aaron Goodman, MD has a financial relationship (Professional Services) with Seattle Genetics.
Manisha Bhattacharya has no relevant financial relationships to disclose at this time.
PLANNING COMMITTEE
Manisha Bhattacharya has no relevant financial relationships to disclose at this time.
Ursa Brown-Glaberman, Associate Professor has a financial relationship (Independent contractor) with SeaGen.
Ronan Hsieh, MD, MS has no relevant financial relationships to disclose at this time.
Darya Kizub, MD has no relevant financial relationships to disclose at this time.
Umang Swami, MD, MS has a financial relationship (Other) with Seattle Genetics; financial relationship (Other) with AstraZeneca; financial relationship (Other) with Exelixis; financial relationship (Other) with Sanofi; financial relationship (Other) with Astellas; financial relationship (Other) with ImVax; financial relationship (Other) with Gilead.
Srinivas Tantravahi, MBBS; MRCP has a financial relationship (Professional Services) with CTI BioPharma; financial relationship (Professional Services) with AbbVie; financial relationship (Professional Services) with Novartis; financial relationship (Financial Support) with karyopharm therapeutics; financial relationship (Professional Services) with MorphoSys.
Dipesh Uprety, MD, FACP has a financial relationship (Professional Services) with Daiichi Sankyo, Astrazeneza, Sanofi and Jazz pharmaceuticals.
Gregory Vidal, MD,PhD has no relevant financial relationships to disclose at this time.
Fengting Yan, MD has no relevant financial relationships to disclose at this time.
Important Information about Claiming CME for this activity:
If you participated in the live course titled -Summit on Cancer Health Disparities (SCHD24) on 04/26/24-04/28/24 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This was recorded from the live course on 04/26/24-04/28/24.
Available Credit
- 14.25 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 14.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 14.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 0.00 Attendance
- 14.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 14.25 Contact Hours.